Total Payments
$1,072
2024 Payments
$480.95
Companies
11
Transactions
34
Medicare Patients
2,501
Medicare Billing
$263,901
Payment Breakdown by Category
Food & Beverage$1,072 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,072 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $233.23 | 18 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $145.10 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $138.24 | 3 | $0 (2020) |
| Gilead Sciences, Inc. | $123.48 | 1 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $115.64 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $114.10 | 1 | $0 (2021) |
| ABBVIE INC. | $86.75 | 5 | $0 (2024) |
| Braintree Laboratories, Inc. | $43.27 | 1 | $0 (2021) |
| Boston Scientific Corporation | $27.87 | 1 | $0 (2019) |
| AIMMUNE THERAPEUTICS, INC. | $23.20 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $480.95 | 8 | Janssen Scientific Affairs, LLC ($145.10) |
| 2023 | $16.10 | 1 | AbbVie Inc. ($16.10) |
| 2022 | $148.00 | 12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($130.24) |
| 2021 | $232.87 | 7 | E.R. Squibb & Sons, L.L.C. ($114.10) |
| 2020 | $141.40 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($127.51) |
| 2019 | $52.20 | 3 | Boston Scientific Corporation ($27.87) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: INFLAM | ||||||
| 11/12/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/01/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $145.10 | General |
| Category: Immunology | ||||||
| 06/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $115.64 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: IMMUNOLOGY | ||||||
| 12/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Gastroenterology | ||||||
| 12/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: Gastroenterology | ||||||
| 12/01/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: Gastroenterology | ||||||
| 08/25/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: Gastroenterology | ||||||
| 08/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Gastroenterology | ||||||
| 07/14/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Gastroenterology | ||||||
| 06/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Gastroenterology | ||||||
| 06/15/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Gastroenterology | ||||||
| 06/15/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: Gastroenterology | ||||||
| 04/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: IMMUNOLOGY | ||||||
| 02/24/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Gastroenterology | ||||||
| 01/20/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Gastroenterology | ||||||
| 12/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Gastroenterology | ||||||
| 12/07/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $114.10 | General |
| Category: Neuroscience | ||||||
| 11/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Gastroenterology | ||||||
| 11/04/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $43.27 | General |
| Category: GI COLON PREP | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 731 | 777 | $319,175 | $76,641 |
| 2022 | 13 | 666 | 702 | $285,255 | $69,156 |
| 2021 | 16 | 679 | 731 | $308,700 | $75,402 |
| 2020 | 12 | 425 | 478 | $185,585 | $42,701 |
Total Patients
2,501
Total Services
2,688
Medicare Billing
$263,901
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $34,650 | $12,380 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 126 | $34,650 | $12,089 | 34.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 51 | 51 | $66,300 | $10,350 | 15.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 94 | 95 | $23,237 | $10,043 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 73 | $13,870 | $4,835 | 34.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $13,750 | $4,070 | 29.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 35 | 36 | $43,200 | $3,915 | 9.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 52 | 53 | $51,145 | $3,853 | 7.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 53 | $6,890 | $3,439 | 49.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 65 | 83 | $6,233 | $3,348 | 53.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 14 | 14 | $12,110 | $2,646 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $5,250 | $2,219 | 42.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,040 | $1,991 | 39.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 15 | $2,850 | $1,464 | 51.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 119 | 119 | $38,230 | $15,003 | 39.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 51 | 51 | $66,300 | $10,786 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 96 | $21,720 | $9,156 | 42.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 56 | 56 | $13,720 | $5,999 | 43.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 66 | 66 | $63,690 | $5,912 | 9.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 70 | $9,100 | $3,921 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 48 | $7,625 | $3,381 | 44.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 23 | $6,720 | $3,132 | 46.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 14 | 14 | $10,230 | $2,631 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $7,525 | $2,490 | 33.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 63 | 71 | $5,325 | $2,149 | 40.4% |
About Dr. Christina Brown, M.D
Dr. Christina Brown, M.D is a Gastroenterology healthcare provider based in Rydal, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1366769895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christina Brown, M.D has received a total of $1,072 in payments from pharmaceutical and medical device companies, with $480.95 received in 2024. These payments were reported across 34 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,072).
As a Medicare-enrolled provider, Brown has provided services to 2,501 Medicare beneficiaries, totaling 2,688 services with total Medicare billing of $263,901. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Rydal, PA
- Active Since 04/23/2010
- Last Updated 03/31/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1366769895
Products in Payments
- XIFAXAN (Drug) $233.23
- TREMFYA (Drug) $145.10
- Livdelzi (Drug) $123.48
- OCALIVA (Drug) $115.64
- ZEPOSIA (Drug) $114.10
- RINVOQ (Biological) $70.65
- SUTAB (Drug) $43.27
- GENERAL ENDOCHOICE (Device) $27.87
- ENTYVIO (Biological) $24.38
- ZENPEP (Drug) $23.20
- VEGZELMA (Biological) $20.64
- SKYRIZI (Biological) $16.10
- Motegrity (Drug) $10.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Rydal
Dr. Stuart Lubinski, M.d, M.D
Gastroenterology — Payments: $14,743
Gastroenterology $14,743
Dr. Cesar Delatorre, M.d, M.D
Gastroenterology — Payments: $2,877
Gastroenterology $2,877
Dr. Daniel Ringold, M.d, M.D
Gastroenterology — Payments: $2,130
Gastroenterology $2,130
Dr. Julia Binder, Md, MD
Gastroenterology — Payments: $1,099
Gastroenterology $1,099
Dr. Eric Goosenberg, M.d, M.D
Gastroenterology — Payments: $971.79
Gastroenterology $971.79
Dr. Joseph Bruno, M.d, M.D
Gastroenterology — Payments: $899.45
Gastroenterology $899.45